Ownership

Colleen F. Reitan

Insider Reports History

Entity: Individual
Location: 300 Third Street, Cambridge, MA
Signature: By: Justin Hunter For: Colleen F. Reitan
All insider transactions: Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Colleen F. Reitan:

Stock	Role	Class	Num Shares	Value	Price $	Report Date	Ownership
MYRIAD GENETICS INC	Director	Common Stock	42.5K	$1.19M	$27.95	Sep 3, 2024	Direct
ALNYLAM PHARMACEUTICALS, INC.	Director	Stock Option (right to buy)	5.23K			May 16, 2024	Direct

Showing 1 to 2 of 2 entries

Insider Reports Filed by Colleen F. Reitan

Symbol	Company	Period	Transactions	Value $	Form Type	Date Filed	Role
MYGN	MYRIAD GENETICS INC	Sep 3, 2024	1	-$1.29M	4	Sep 4, 2024	Director
MYGN	MYRIAD GENETICS INC	Jun 6, 2024	1	$0	4	Jun 7, 2024	Director
ALNY	ALNYLAM PHARMACEUTICALS, INC.	May 16, 2024	1	$0	4	May 20, 2024	Director
MYGN	MYRIAD GENETICS INC	Jun 1, 2023	1	$0	4	Jun 2, 2023	Director
ALNY	ALNYLAM PHARMACEUTICALS, INC.	May 18, 2023	1	$0	4	May 19, 2023	Director
MYGN	MYRIAD GENETICS INC	Jun 2, 2022	1	$0	4	Jun 3, 2022	Director
ALNY	ALNYLAM PHARMACEUTICALS, INC.	May 18, 2022	1	$0	4	May 20, 2022	Director
ALNY	ALNYLAM PHARMACEUTICALS, INC.	Jul 15, 2021	1	$0	4	Jul 19, 2021	Director
MYGN	MYRIAD GENETICS INC	Jun 3, 2021	1	$0	4	Jun 4, 2021	Director